Abstract:BACKGROUND:Cancer stem cells (CSCs) are widely thought to contribute to the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC). CSCs share biological features with adult stem cells, such as longevity, self-renewal capacity, differentiation, drug resistance, and the requirement for a niche; these features play a decisive role in cancer progression. A prominent characteristic of PDAC is metabolic reprogramming, which provides sufficient nutrients to support rapid tumor cell growth. However, whether PDAC stemness is correlated with metabolic reprogramming remains unknown.METHOD:RNA sequencing data of PDAC, including read counts and fragments per kilobase of transcript per million mapped reads (FPKM), were collected from The Cancer Genome Atlas-Pancreatic Adenocarcinoma (TCGA-PAAD) database. Single-sample gene set enrichment analysis (GSEA) was used to calculate the relative activities of metabolic pathways in each PDAC sample. Quantitative real-time PCR was performed to validate the expression levels of genes of interest.RESULTS:The overall survival (OS) of patients with high mRNA expression-based stemness index (mRNAsi) values was significantly worse than that of their counterparts with low mRNAsi values (P = 0.003). This survival disadvantage was independent of baseline clinical characteristics. Gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and GSEA showed that the differentially expressed genes between patients with high and low mRNAsi values were mainly enriched in oncogenic and metabolic pathways. Weighted gene coexpression network analysis (WGCNA) revealed 8 independent gene modules that were significantly associated with mRNAsi and 12 metabolic pathways. Unsupervised clustering based on the key genes in each module identified two PDAC subgroups characterized by different mRNAsi values and metabolic activities. Univariate Cox regression analysis identified 14 genes beneficial to OS from 95 key genes selected from the eight independent gene modules from WGCNA. Among them, MAGEH1, MAP3K3, and PODN were downregulated in both pancreatic tissues and cell lines.CONCLUSION:The present study showed that PDAC samples with high mRNAsi values exhibited aberrant activation of multiple metabolic pathways, and the patients from whom these samples were obtained had a poor prognosis. Future studies are expected to investigate the underlying mechanism based on the crosstalk between PDAC stemness and metabolic rewiring.

Analysis on gene expression profile of human pancreatic cancer stem cells by gene microarray

Proteome of Human Colon Cancer Stem Cells: A Comparative Analysis

Analysis of Whole Genomic Expression Profiles and Screening of the Key Signaling Pathways Associated with Pancreatic Cancer.

Analysis of biological behavior of tumor stem cell of pancreatic adenocarcinoma cell line PANC-1

Isolation and Biological Analysis of Tumor Stem Cells from Pancreatic Adenocarcinoma

Screening the Human Pancreatic Cancer-Associated Genes by Cdna Microarray

DNA Microarray Analysis of Gene Expression Profiles in Pancreatic Carcinoma

The isolation and functional verification of tumor stem cells in pancreatic adenocarcinoma

The Isolation and Functional Verification of the Cells with CD24CD44 Double Positive Expression from Primary Human Pancreatic Adenocarcinomas

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Microarray-based analysis of microRNA expression in breast cancer stem cells

Single-cell Transcriptome Reveals the Heterogeneity of Malignant Ductal Cells and the Prognostic Value of REG4 and SPINK1 in Primary Pancreatic Ductal Adenocarcinoma

Study of Differentially Expressed Genes in Pancreatic Cancer by cDNA Microarray

Isolation and Identiffcation of Cancer Stem-Like Side Population Cells in Pancreatic Cancer

Human pancreatic carcinoma cell lines express markers of stem cell

Notch2 Expression in Association with Pancreatic Cancer Stem Cells

Identification of the Roles of a Stemness Index Based on Mrna Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma.

Analysis of Gene Expression Patterns in Pancreatic Cancer by Cdna Micro Array

Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

Identification of Side Population Cells Like Cancer Stem Cell in Human Pancreatic Cancer Cell Line SW1990

Analysis of Gene Expression Profiles in Pancreatic Carcinoma by Using Cdna Microarray.